Vanda Pharmaceuticals Reports Second Quarter 2025 Financial Results

Go back to Vanda Pharmaceuticals Reports Second Quarter 2025 Financial Results
Vanda Pharmaceuticals, Inc. (NASDAQ: VNDA) Delayed: 5.26 -0.02 (0.38%)
Previous Close $5.28    52 Week High $18.00 
Open $5.37    52 Week Low $6.91 
Day High $5.37    P/E N/A 
Day Low $5.23    EPS $-0.67 
Volume 43,431